Found 7 results
Filters: Author is H.L. Yang  [Clear All Filters]
H. L. Yang, Yan, J., Feng, M., Tan, X., Yan, G. Y., Gan, L., and Sun, C., Construction of suppressor of cytokine signaling 2 (SOCS2) adenoviral overexpression vector and its impact on growth-hormone-induced lipolysis in swine primary adipocytes, vol. 12, pp. 1283-1293, 2013.
Berryman DE, List EO, Coschigano KT, Behar K, et al. (2004). Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14: 309-318. PMid:15231300   Flores-Morales A, Fernandez L, Rico-Bautista E, Umana A, et al. (2001). Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway. Mol. Endocrinol. 15: 1471-1483. PMid:11518796   Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, et al. (2002). Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277: 40181-40184. PMid:12208853   Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, et al. (2005). SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115: 397-406. PMid:15690087 PMCid:546423   Johansen T, Richelsen B, Hansen HS, Din N, et al. (2003). Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm. Metab. Res. 35: 243-250. PMid:12778368   Kawai M, Namba N, Mushiake S, Etani Y, et al. (2007). Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARgamma pathway. J. Mol. Endocrinol. 38: 19-34. PMid:17242167   Leung KC, Doyle N, Ballesteros M, Sjogren K, et al. (2003). Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. U. S. A. 100: 1016-1021. PMid:12552091 PMCid:298718   Louveau I and Gondret F (2004). Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system. Domest. Anim. Endocrinol. 27: 241-255. PMid:15451072   Metcalf D, Greenhalgh CJ, Viney E, Willson TA, et al. (2000). Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405: 1069-1073. PMid:10890450   Miller ME, Michaylira CZ, Simmons JG, Ney DM, et al. (2004). Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127: 570-581. PMid:15300589   Ng FM, Jiang WJ, Gianello R, Pitt S, et al. (2000). Molecular and cellular actions of a structural domain of human growth hormone (AOD9401) on lipid metabolism in Zucker fatty rats. J. Mol. Endocrinol. 25: 287-298. PMid:11116208   Ouyang X, Fujimoto M, Nakagawa R, Serada S, et al. (2006). SOCS-2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells. J. Cell Physiol. 207: 428-436. PMid:16419040   Pasarica M, Zachwieja JJ, Dejonge L, Redman S, et al. (2007). Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 92: 4265-4270. PMid:17785361   Paul C, Seiliez I, Thissen JP and Le CA (2000). Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur. J. Biochem. 267: 5849-5857. PMid:10998044   Plockinger U and Reuter T (2008). Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. Eur. J. Endocrinol. 158: 467-471. PMid:18362292   Rico-Bautista E, Negrin-Martinez C, Novoa-Mogollon J, Fernandez-Perez L, et al. (2004). Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Exp. Cell Res. 294: 269-280. PMid:14980520   Stewart WC, Baugh JE Jr, Floyd ZE and Stephens JM (2004). STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 324: 355-359. PMid:15465026   Sun C, Wang L, Yan J and Liu S (2012a). Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol. Biol. Rep. 39: 1755-1763. PMid:21633889   Sun C, Qi R, Wang L, Yan J, et al. (2012b). p38 MAPK regulates calcium signal-mediated lipid accumulation through changing VDR expression in primary preadipocytes of mice. Mol. Biol. Rep. 39: 3179-3184. PMid:21701827   Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Sahlin L, et al. (1999). Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140: 3693-3704. PMid:10433229   Turnley AM (2005). Role of SOCS2 in growth hormone actions. Trends Endocrinol. Metab. 16: 53-58. PMid:15734145   Zhang Y, Zhao J, Zhang H, Gai Y, et al. (2010). The involvement of suppressors of cytokine signaling 2 (SOCS2) in immune defense responses of Chinese mitten crab Eriocheir sinensis. Dev. Comp. Immunol. 34: 42-48. PMid:19686773
D. F. Jiang, Zhang, X. G., Yang, H. L., and Sun, C., Differential expression of lipid metabolism genes in the liver and adipose tissue of mice treated with evodiamine, vol. 12, pp. 1501-1510, 2013.